Viewing StudyNCT00110929



Ignite Creation Date: 2024-05-05 @ 11:42 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00110929
Status: COMPLETED
Last Update Posted: 2010-04-23
First Post: 2005-05-16

Brief Title: Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease ESRD
Sponsor: Amgen
Organization: Amgen

Organization Data

Organization: Amgen
Class: INDUSTRY
Study ID: 20020158
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Amgen
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Global Development Leader
Old Organization: Amgen Inc

Collaborators